KYLA KNIES: Open Payments
NPI 1407335094 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 10 payments from 8 companies in 2025. Trend: 2023 $192 · 2024 $331 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $26 |
| Novo Nordisk Inc | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: REPATHA, FARXIGA, JARDIANCE, FREESTYLE LIBRE 3, Wegovy, EVKEEZA, LEQVIO, CAMZYOS.
Industry payments across IN — which companies pay providers there.
